• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

TruBridge | Streamlining Healthcare Solutions for Future Growth

Share:

March 1, 2024

CPSI, now TruBridge, Inc., has rebranded to streamline healthcare solutions, enhance market presence, and foster future growth. This unified approach aims to simplify client access to comprehensive technology solutions, bolster the company’s standing in the market, and capitalize on emerging opportunities. Chris Fowler, President and CEO, emphasizes TruBridge’s commitment to bridging healthcare gaps and empowering providers for improved outcomes.

CPSI, listed on NASDAQ as CPSI, has recently announced a strategic shift in branding, reemerging as TruBridge, Inc. as of March 4, 2024.

This rebranding signifies a decisive move towards a more cohesive approach, aimed at consolidating its solutions, fortifying its market position, and propelling future expansion under a singular identity.

Unified under the banner of TruBridge, the company underscores its commitment to establishing a seamless connection between efficient financial management and high-quality clinical care. This transformation aims to achieve several key objectives:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Streamlining offerings: TruBridge endeavors to provide clients with a unified platform for accessing a comprehensive range of healthcare technology solutions, simplifying their experience through a single point of contact.

– Strengthening market presence: By presenting a unified front, TruBridge solidifies its stature as a prominent entity within the healthcare technology sector, poised to attract new clientele and forge strategic partnerships.

– Facilitating future growth: Focused on its core competencies, TruBridge positions itself to capitalize on emerging opportunities and navigate evolving industry dynamics adeptly.

Chris Fowler, President and CEO of CPSI, remarked, “Under the unified banner of TruBridge, our collective focus is on bridging healthcare gaps, empowering providers, and enhancing financial and clinical outcomes through timely, community-focused solutions.”

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • KD Pharma Acquires Rohner AG Manufacturing AssetsKD Pharma Acquires Rohner AG Manufacturing Assets
  • SUPRIYA Lifescience Strategic Growth Through Advanced ManufacturingSUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Pharma and Healthcare Social Media Marketing Market 2021 Size, Growth Analysis Report, Forecast to 2030Pharma and Healthcare Social Media Marketing Market 2021 Size, Growth Analysis Report, Forecast to 2030
  • Galt Acquires Arrotek MedicalGalt Acquires Arrotek Medical
  • CareMount, Nuvance Partner to Expand Population Health Services in NYCareMount, Nuvance Partner to Expand Population Health Services in NY
  • Focus Healthcare Partners and Life Care Services Enhance Iconic Continuing Care/Life Plan Community located in Fairfax, VirginiaFocus Healthcare Partners and Life Care Services Enhance Iconic Continuing Care/Life Plan Community located in Fairfax, Virginia
  • Global Venlafaxine Hydrochloride Market Growth Prospects, Insight Analysis 2020-2024 | Pfizer, Mesha Pharma, Sun Pharmaceutical Industries, Taj APIGlobal Venlafaxine Hydrochloride Market Growth Prospects, Insight Analysis 2020-2024 | Pfizer, Mesha Pharma, Sun Pharmaceutical Industries, Taj API
  • Noema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris PartnersNoema Pharma raises CHF54 million in Series A financing round led by Sofinnova Partners and Polaris Partners

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications